Video Transcript: Patient Spotlight – Cherie T.
Biologics by McKesson Patient Voice Spotlight – Cherie T. Cherie T., Biologics by McKesson Oncology Patient: Twenty-one years ago, I […]
Video Transcript: Patient Spotlight – Nicole B.
Biologics by McKesson Patient Voice Spotlight – Nicole B. Nicole B., Biologics by McKesson Oncology Patient: I was first diagnosed […]
Video Transcript: Patient Spotlight – Karen I.
Biologics by McKesson Patient Voice Spotlight – Karen I. Karen I., Biologics by McKesson Oncology Patient: I was diagnosed in […]
Video Transcript: Patient Spotlight – Larry H.
Biologics by McKesson Patient Voice Spotlight – Larry H. Larry H., Biologics by McKesson Oncology Patient: I was diagnosed in […]
NULIBRY (fosdenopterin), First and Only FDA-Approved Therapy to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency Type A, Available Exclusively at Biologics by McKesson
CARY, N.C., April 19, 2021—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]
SYNGAP1 Foundation Q&A
The SYNGAP1 Foundation was founded in 2014. Today, it is the leading non-profit patient advocacy group dedicated to improving the quality of life for patients and families affected by the rare SYNGAP1 gene mutation or a variant.